Document is current
Any future updates will be listed below
-
Authors
Wiscovitch-Russo, Rosana
Ibáñez-Prada, Elsa D.
Serrano-Mayorga, Cristian C.
Sievers, Benjamin L.
Engelbride, Maeve A.
Padmanabhan, Surya
Tan, Gene S.
Vashee, Sanjay
Bustos, Ingrid G.
Pachecho, Carlos
Mendez, Lina
Dube, Peter H.
Singh, Harinder
Reyes, Luis Felipe
Gonzalez-Juarbe, Norberto
-
Funding
Funding for this research was provided by:
Conrad Prebys Foundation (204)
National Institutes of Health (R01AI137365, AI148722-01A1,)
Universidad de La Sabana (MED-311-2021)
- License Information
-
More Information
Article History
Received: 11 January 2023
Accepted: 30 March 2023
First Online: 20 April 2023
Declarations
:
: For human participants and data, this study was approved by the Institutional Review Board (IRB) of the Clínica Universidad de La Sabana, and all patients signed informed consent to participate in the study (CUS-LFR-012). For the animal study, golden Syrian hamsters 3–4 weeks old were purchased from Charles River Laboratory and used at 5–6 weeks of age. All procedures were per approved IACUC (2020040AR and 2020048AR) and Institutional Biosafety Committee protocols (08496).
: Not Applicable.
: We declare that none of the authors has competing financial or financial interests. LFR receives research funding and personal fees outside this manuscript's subject from Merck, Pfizer, and GSK.
